[1]
|
Moses, W., Weng, J. and Kebebew, E. (2011) Prevalence, Clinico-Pathologic Features, and Somatic Genetic Mutation Profile in Familial versus Sporadic Nonmedullary Thyroid Cancer. Thyroid, 21, 367-371.
https://doi.org/10.1089/thy.2010.0256
|
[2]
|
赫捷, 李进, 程颖, 樊嘉, 郭军, 江泽飞, 于金明. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021 [J]. 肿瘤预防与治疗, 2021, 34(12): 1164-1200.
|
[3]
|
《中国肿瘤临床》文章推荐: 中国家族遗传性肿瘤临床诊疗专家共识(2021年版)——家族遗传性乳腺癌[J]. 中国肿瘤临床, 2022, 49(14): 742.
|
[4]
|
Charkes, N.D. (2006) On the Prevalence of Familial Nonmedullary Thyroid Cancer in Multiply Af-fected Kindreds. Thyroid, 16, 181-186. https://doi.org/10.1089/thy.2006.16.181
|
[5]
|
El Lakis, M., Giannakou, A., Nockel, P.J., et al. (2019) Do Patients with Familial Nonmedullary Thyroid Cancer Present with More Aggressive Dis-ease? Implications for Initial Surgical Treatment. Surgery, 165, 50-57.
https://doi.org/10.1016/j.surg.2018.05.075
|
[6]
|
Zhang, Y.B., Wang, X.X., Zhang, X.W., Li, Z.J., Liu, J., Xu, Z.G. and Tang, P.Z. (2018) Familial Nonmedullary Thyroid Carcinoma: A Retrospective Analysis of 117 Families. Chinese Medical Journal (England), 131, 395-401.
https://doi.org/10.4103/0366-6999.225054
|
[7]
|
Tavarelli, M., Russo, M., Terranova, R., Scollo, C., Spadaro, A., Sapuppo, G., et al. (2015) Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families. Frontiers in Endocrinology (Lausanne), 6, Article No. 117.
https://doi.org/10.3389/fendo.2015.00117
|
[8]
|
Sezer, H., Demirkol, M.O., Yazici, D., Kapran, Y. and Alagöl, M.F. (2020) The Clinicopathologic Characteristics of Familial and Sporadic Papillary Thyroid Carcinoma in Turkish Patients. Turkish Journal of Medical Sciences, 50, 360-368. https://doi.org/10.3906/sag-1907-94
|
[9]
|
Pasquali, D., Torella, A., Accardo, G., Esposito, D., Del Vecchio Blanco, F., Salvatore, D., Sabatino, P., Pacini, F., Barbato, F., Castagna, M.G., Cantara, S. and Nigro, V. (2021) BROX Haploinsufficiency in Familial Nonmedullary Thyroid Cancer. Journal of Endocrinological Investigation, 44, 165-171. https://doi.org/10.1007/s40618-020-01286-6
|
[10]
|
Wang, X., Cheng, W., Li, J., et al. (2015) Endocrine Tumours: Familial Nonmedullary Thyroid Carcinoma Is a More Aggressive Disease: A Systematic Review and Meta-Analysis. European Journal of Endocrinology, 172, R253-R262.
https://doi.org/10.1530/EJE-14-0960
|
[11]
|
Klubo-Gwiezdzinska, J., Yang, L., Merkel, R., Patel, D., Nilubol, N., Merino, M.J., et al. (2017) Results of Screening in Familial Non-Medullary Thyroid Cancer. Thyroid, 27, 1017-1024. https://doi.org/10.1089/thy.2016.0668
|
[12]
|
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D.C., Curry, S.J., Barry, M.J., Davidson, K.W., Doubeni, C.A., Epling, J.W., et al. (2017) Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 317, 1882-1887. https://doi.org/10.1001/jama.2017.4011
|
[13]
|
Li, J.M., Li, H.R., Yang, Y., et al. (2020) The KWAK TI-RADS and 2015 ATA Guidelines for Medullary Thyroid Carcinoma: Combined with Cell Block Assisted Ultrasound-Guided Thy-roid Fine-Needle Aspiration. Clinical Endocrinology (Oxford), 92, 450-460. https://doi.org/10.1111/cen.14121
|
[14]
|
Zhao, J., Yang, F., Wei, X., et al. (2021) Ultrasound Features Value in the Diagnosis and Prognosis of Medullary Thyroid Carcinoma. Endocrine, 72, 727-734. https://doi.org/10.1007/s12020-020-02510-2
|
[15]
|
Capezzone, M., Sagnella, A., Pilli, T., Maino, F., Forleo, R., Cantara, S., et al. (2021) Role of Age at Diagnosis in Defining Potential Familial Nonmedullary Thyroid Cancer in Kin-dreds with Two Affected Members. The Journal of Clinical Endocrinology & Metabolism, 106, e855-e865. https://doi.org/10.1210/clinem/dgaa798
|
[16]
|
Grani, G., Cera, G., Conzo, G., Del Gatto, V., di Gioia, C.R.T., Ma-ranghi, M., et al. (2021) Preoperative Ultrasonography in the Evaluation of Suspected Familial Non-Medullary Thyroid Cancer: Are We Able to Predict Multifocality and Extrathyroidal Extension? Journal of Clinical Medicine, 10, Article No. 5277.
https://doi.org/10.3390/jcm10225277
|
[17]
|
Peiling Yang, S. and Ngeow, J. (2016) Familial Non-Medullary Thyroid Cancer: Unraveling the Genetic Maze. Endocrine-Related Cancer, 23, R577-R595. https://doi.org/10.1530/ERC-16-0067
|
[18]
|
Srivastava, A., Kumar, A., Giangiobbe, S., et al. (2019) Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways. Biomolecules, 9, Article No. 605. https://doi.org/10.3390/biom9100605
|
[19]
|
de Mello, L.E.B., Carneiro, T.N.R., Araujo, A.N., Alves, C.X., Galante, P.A.F., Buzatto, V.C., et al. (2022) Identification of NID1 as a Novel Candidate Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma Using Whole-Exome Sequencing. Endocrine Connections, 11, e210406. https://doi.org/10.1530/EC-21-0406
|
[20]
|
Miasaki, F.Y., Fuziwara, C.S., Carvalho, G.A. and Kimura, E.T. (2020) Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer. Genes (Basel), 11, Article No. 1364.
https://doi.org/10.3390/genes11111364
|
[21]
|
The Human Protein Atlas. https://www.proteinatlas.org
|
[22]
|
Orois, A., Gara, S.K., Mora, M., Halperin, I., Martinez, S., Alfayate, R., et al. (2019) NOP53 as a Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer. Genes (Basel), 10, Article No. 899.
https://doi.org/10.3390/genes10110899
|
[23]
|
Ammar, S.A., Alobuia, W.M. and Kebebew, E. (2020) An Update on Familial Nonmedullary Thyroid Cancer. Endocrine, 68, 502-507. https://doi.org/10.1007/s12020-020-02250-3
|
[24]
|
Lebbink, C.A., Links, T.P., Czarniecka, A., Dias, R.P., Elisei, R., Izatt, L., et al. (2022) 2022 European Thyroid Association Guidelines for the Management of Pediatric Thyroid Nodules and Differentiated Thyroid Carcinoma. European Thyroid Journal, 11, e220146. https://doi.org/10.1530/ETJ-22-0146
|
[25]
|
刀钰洋, 冯志平, 陈媛娇, 陈婷. 家族性非髓样甲状腺癌致病基因与易感基因的研究进展[J]. 临床肿瘤学杂志, 2022, 27(6): 561-566.
|
[26]
|
Muallem Kalmovich, L., Jabarin, B., Koren, S., Or, K., Marcus, E., Tkacheva, I., et al. (2021) Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer? Laryngoscope, 131, E677-E681.
https://doi.org/10.1002/lary.28989
|
[27]
|
Ito, Y., Hirokawa, M., Higashiyama, T., et al. (2012) Biological Behavior of Papillary Carcinoma of the Thyroid Including Squamous Cell Carcinoma Components and Prognosis of Patients Who Underwent Locally Curative Surgery. Journal of Thyroid Research, 2012, Article ID: 230283. https://doi.org/10.1155/2012/230283
|
[28]
|
Jegerlehner, S., Bulliard, J.L., Aujesky, D., Rodondi, N., Germann, S., Konzelmann, I., Chiolero, A. and NICER Working Group (2017) Overdiagnosis and Overtreatment of Thyroid Cancer: A Population-Based Temporal Trend Study. PLOS ONE, 12, e0179387. https://doi.org/10.1371/journal.pone.0179387
|
[29]
|
Mazeh, H. and Sippel, R.S. (2013) Familial Nonmedullary Thyroid Carcinoma. Thyroid, 23, 1049-1056.
https://doi.org/10.1089/thy.2013.0079
|
[30]
|
Uchino, S., Noguchi, S., Kawamoto, H., Yamashita, H., Watanabe, S., Yamashita, H. and Shuto, S. (2002) Familial Nonmedullary Thyroid Carcinoma Characterized by Multifocality and a High Recurrence Rate in a Large Study Population. World Journal of Surgery, 26, 897-902. https://doi.org/10.1007/s00268-002-6615-y
|
[31]
|
Alsanea, O. (2000) Familial Nonmedullary Thyroid Cancer. Cur-rent Treatment Options in Oncology, 1, 345-351.
https://doi.org/10.1007/s11864-000-0050-9
|
[32]
|
Malchoff, C.D. (2021) Inherited Risk Factors for Nonmedullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 106, e4287-e4289. https://doi.org/10.1210/clinem/dgab185
|
[33]
|
Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., et al. (2019) SEER Cancer Statistics Review, 1975-2016. National Cancer Institute, Bethesda.
|
[34]
|
Paulson, V.A., Rudzinski, E.R. and Hawkins, D.S. (2019) Thyroid Cancer in the Pediatric Population. Genes, 10, Article No. 723. https://doi.org/10.3390/genes10090723
|
[35]
|
Hogan, A.R., Zhuge, Y., Perez, E.A., Koniaris, L.G., Lew, J.I. and Sola, J.E. (2009) Pediatric Thyroid Carcinoma: Incidence and Outcomes in 1753 Patients. Journal of Surgical Research, 156, 167-172.
https://doi.org/10.1016/j.jss.2009.03.098
|
[36]
|
Capezzone, M., Maino, F., Sagnella, A., Campanile, M., Dalmiglio, C., Pilli, T., et al. (2021) Clinical Features of Pediatric Familial Non-Medullary Thyroid Cancer (FNMTC). Journal of Endocrinological Investigation, 44, 2319-2321.
https://doi.org/10.1007/s40618-021-01520-9
|
[37]
|
Spinelli, C., Piccolotti, I., Bertocchini, A., Morganti, R., Ma-terazzi, G., Tonacchera, M. and Strambi, S. (2021) Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience. World Journal of Surgery, 45, 2473-2479. https://doi.org/10.1007/s00268-021-06104-5
|
[38]
|
Francis, G.L., Waguespack, S.G., Bauer, A.J., Angelos, P., Benvenga, S., Cerutti, J.M., et al. (2015) Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 25, 716-759.
https://doi.org/10.1089/thy.2014.0460
|
[39]
|
Capezzone, M., Sagnella, A., Cantara, S., Fralassi, N., Maino, F., For-leo, R., et al. (2022) Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients. Frontiers in Endocrinology (Lausanne), 13, Article ID: 845954. https://doi.org/10.3389/fendo.2022.845954
|
[40]
|
Gudmundsson, J., Thorleifsson, G., Sigurdsson, J.K., Stefansdot-tir, L., Jonasson, J.G., Gudjonsson, S.A., et al. (2017) A Genome-Wide Association Study Yields Five Novel Thyroid Cancer Risk Loci. Nature Communications, 8, Article No. 14517. https://doi.org/10.1038/ncomms14517
|
[41]
|
Lee, Y.M., Jeon, M.J., Kim, W.W., Chung, K.W., Baek, J.H., Shong, Y.K., Sung, T.Y. and Hong, S.J. (2021) Comparison between Familial and Sporadic Non-Medullary Thyroid Carcinoma: A Retrospective Individual Risk Factor-Matched Cohort Study. Annals of Surgical Oncology, 28, 1722-1730. https://doi.org/10.1245/s10434-020-09025-0
|
[42]
|
Valerio, L., Cantara, S., Puxeddu, E. and Castagna, M.G. (2022) Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update. Frontiers in Endo-crinology (Lausanne), 13, Article ID: 891903.
https://doi.org/10.3389/fendo.2022.891903
|